Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sagar Lonial

Showing results (141-150 of 440) with videos related to

Pageof 44
Sort By:
Seminars in Oncology|February 26, 2014
High-risk myeloma: when to transplant-or notDonald M Eicher, Sagar Lonial, Federica Cavallo, et al.
Molecular Cancer Therapeutics|July 3, 2007
The alkylphospholipid perifosine induces apoptosis of human lung cancer cells requiring inhibition of Akt and activation of the extrinsic apoptotic pathwayHeath A Elrod, Yi-Dan Lin, Ping Yue, et al.
Cancer|April 7, 2006
Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myelomaBrett T Brinker, Edmund K Waller, Traci Leong, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2025
AI-informed retinal biomarkers predict 10-year risk of onset of multiple hematological malignanciesAmritpal Singh, Ajay K Nooka, Gourav Modanwal, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 28, 2026
High-Risk Multiple Myeloma: Redefining Risk and Rethinking TherapyGareth J Morgan, Dennis D Lee, Nisha S Joseph, et al.
Cancer|October 11, 2018
Response to therapeutic monoclonal antibodies for multiple myeloma in African Americans versus whitesSarah Chehab, Chao Zhang, Elyse H Panjic, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 19, 2003
Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantationEdmund K Waller, Amelia A Langston, Sagar Lonial, et al.
Nucleic Acids Research|December 2, 2016
MAX is an epigenetic sensor of 5-carboxylcytosine and is altered in multiple myelomaDongxue Wang, Hideharu Hashimoto, Xing Zhang, et al.
Cancer Research|November 19, 2009
Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagyLei Fu, Young-Ae Kim, Xuerong Wang, et al.
Blood Cancer Journal|September 8, 2018
Lenalidomide and dexamethasone in patients with relapsed multiple myeloma and impaired renal function: PrE1003, a PrECOG studyJoseph Mikhael, Judith Manola, Amylou C Dueck, et al.
Pageof 44

Showing results (141-150 of 440) with videos related to

Sort By:
Pageof 44
Seminars in Oncology|February 26, 2014
High-risk myeloma: when to transplant-or notDonald M Eicher, Sagar Lonial, Federica Cavallo, et al.
Molecular Cancer Therapeutics|July 3, 2007
The alkylphospholipid perifosine induces apoptosis of human lung cancer cells requiring inhibition of Akt and activation of the extrinsic apoptotic pathwayHeath A Elrod, Yi-Dan Lin, Ping Yue, et al.
Cancer|April 7, 2006
Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myelomaBrett T Brinker, Edmund K Waller, Traci Leong, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2025
AI-informed retinal biomarkers predict 10-year risk of onset of multiple hematological malignanciesAmritpal Singh, Ajay K Nooka, Gourav Modanwal, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 28, 2026
High-Risk Multiple Myeloma: Redefining Risk and Rethinking TherapyGareth J Morgan, Dennis D Lee, Nisha S Joseph, et al.
Cancer|October 11, 2018
Response to therapeutic monoclonal antibodies for multiple myeloma in African Americans versus whitesSarah Chehab, Chao Zhang, Elyse H Panjic, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 19, 2003
Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantationEdmund K Waller, Amelia A Langston, Sagar Lonial, et al.
Nucleic Acids Research|December 2, 2016
MAX is an epigenetic sensor of 5-carboxylcytosine and is altered in multiple myelomaDongxue Wang, Hideharu Hashimoto, Xing Zhang, et al.
Cancer Research|November 19, 2009
Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagyLei Fu, Young-Ae Kim, Xuerong Wang, et al.
Blood Cancer Journal|September 8, 2018
Lenalidomide and dexamethasone in patients with relapsed multiple myeloma and impaired renal function: PrE1003, a PrECOG studyJoseph Mikhael, Judith Manola, Amylou C Dueck, et al.
Pageof 44